Bayer MaterialScience Invests in Medical Technology
January 11, 2010
Bayer MaterialScience has entered into an agreement to acquire PolyBioMed Ltd. based in Sheffield, UK, expanding its product portfolio for medical technology. PolyBioMed, a subsidiary of Lombard Medical Technologies, provides polymer coatings, surface treatments and biomaterials to the medical device industry. The acquisition gives Bayer MaterialScience access to application areas such as coronary drug-eluting stents plus catheter systems for interventional cardiology, urology and neurology. The aim is to provide materials which can enhance design, manufacturing and end-use performance for a variety of medical devices. Bayer MaterialScience is looking to further develop its own polyurethane-based hydrophilic coatings for medical devices with PolyBioMed’s technologies to offer an extended portfolio of surface modification techniques.